Skip to content

Study on Breast Cancer Factors and a New Herbal Anti Cancer Therapy

CROSS-SECTIONAL ETIOLOGICAL STUDY OF BREAST CANCER AND THE ANTI CANCER EFFECT OF AYUR BC 3: AN IN VIVO EXPERIMENTAL STUDY - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/12/098896
Enrollment
500
Registered
2025-12-11
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C509- Malignant neoplasm of breast of unspecified site

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Histologically confirmed diagnosis of primary breast carcinoma (current) OR documented history of treated breast carcinoma (including date of diagnosis and treatment summary available in medical records). Physically and mentally able to participate in an interview / complete the questionnaire (self-completed or interviewer-assisted).

Exclusion criteria

Exclusion criteria: No confirmatory documentation for breast cancer diagnosis (no histopathology, unavailable records, or inconclusive diagnosis). Current severe medical, cognitive, or psychiatric condition that prevents reliable participation or informed consent (e.g., severe delirium, advanced dementia). Individuals who decline participation or withdraw consent at any point.

Design outcomes

Primary

MeasureTime frame
To assess the etiological factors (Risk factors) of breast cancer in Rajasthan state and evaluate as per concept of ayurvedaTimepoint: on the day of survey (Baseline)

Secondary

MeasureTime frame
nilTimepoint: nil

Countries

India

Contacts

Public ContactDr Jitendra Sankhala

National Institute of Ayurveda Jaipur

jeetsankhla11@gmail.com7976126960

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026